Predictive Vulnerability Intelligence.

Product

  • Product
  • Pricing
  • Documentation

Company

  • About
  • Partnerships
  • Blog
  • Support

Legal

  • Terms
  • Privacy
  • Data Licensing

© 2026 FAUCET Technologies LLC. All rights reserved.

CVE-2019-15933

27
FAUCET Score

CVE-2019-15933 is a critical SQL Injection vulnerability affecting Intesync Solismed 3.3sp, allowing unauthenticated attackers to execute arbitrary SQL commands. With a CVSS score of 9.8, it presents a high risk due to its network-based attack vector, low complexity, and potential for complete compromise of confidentiality, integrity, and availability. While there is no evidence of active exploitation, nor publicly available exploit code or significant community discussion, organizations using affected versions should prioritize patching.

Impacted Technologies

VendorProductVersion(s)CPE
3.3CPE matchmatch criteria
cpe:2.3:a:intesync:solismed:3.3:sp1:*:*:*:*:*:*

CVSS Data

CVSS version used by this source: 3.1

9.8CRITICAL

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H

Attack Vector
NETWORK
Attack Complexity
LOW
Privileges Required
NONE
User Interaction
NONE
Scope
UNCHANGED
Confidentiality Impact
HIGH
Integrity Impact
HIGH
Availability Impact
HIGH
Exploitability Score
3.9
Impact Score
5.9
CvssVersion
3.1

Exploit Intelligence

EPSS Score
2.00%
Probability of exploitation in next 30 days
EPSS Percentile
78.6%
Percentile rank of EPSS score among Peer Group
As of 2026-07-27
Model: v2026.06.15
This CVE's current EPSS score of 0.0200 is in the 67th percentile among its peer group of 36,835 CVEs.

Social Chatter

The average CVE in this peer group has 0.0 Twitter, 0.1 Reddit, 0.3 Bluesky, 0.3 Mastodon, and 2.4 GitHub mentions.

Media Mentions

No media coverage found for this CVE.

The average CVE in this peer group has 0.3 InfoSec Media, 0.0 Vendor Blog, and 0.0 Security Researcher mentions.

Remediation

Remediation records are not available for this CVE.

References

bishopfox.com
Third Party Advisory
know.bishopfox.com / advisories/solismed-critical
ExploitThird Party Advisory
bishopfox.com / blog/news-category/advisories
Third Party Advisory
solismed.com
Product